-
公开(公告)号:US08642601B2
公开(公告)日:2014-02-04
申请号:US13151326
申请日:2011-06-02
申请人: Humberto Bartolome Arzeno , Lubov K. Filonova , David Michael Goldstein , Leyi Gong , Bradley E. Loe , Erin M. O'Brien , Wylie Solang Palmer , David Mark Rotstein , Tania M. Silva , Yun-Chou Tan
发明人: Humberto Bartolome Arzeno , Lubov K. Filonova , David Michael Goldstein , Leyi Gong , Bradley E. Loe , Erin M. O'Brien , Wylie Solang Palmer , David Mark Rotstein , Tania M. Silva , Yun-Chou Tan
IPC分类号: A01N43/54 , C07D239/12 , C07D401/04 , C07D471/04 , C07D471/22 , C07D487/04 , A01N43/56 , A61K31/415
CPC分类号: C07D403/04 , C07D401/04 , C07D401/14 , C07D403/14 , C07D409/14 , C07D487/02
摘要: Compounds of formula I or pharmaceutically acceptable salts thereof, wherein R5 is a group of formula (a) or (b): and wherein m, n, p, q, X, Y, R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as defined herein. The compounds and compositions disclosed herein are useful to modulate the activity of JNK and treat diseases associated with JNK activity.
摘要翻译: 式I化合物或其药学上可接受的盐,其中R 5是式(a)或(b)的基团:其中m,n,p,q,X,Y,R 1,R 2,R 3,R 4,R 5,R 6 ,R7,R8和R9如本文所定义。 本文公开的化合物和组合物可用于调节JNK的活性并治疗与JNK活性相关的疾病。
-
公开(公告)号:US20070135427A1
公开(公告)日:2007-06-14
申请号:US11636037
申请日:2006-12-08
申请人: Leyi Gong , Counde O'Yang , Yun-chou Tan
发明人: Leyi Gong , Counde O'Yang , Yun-chou Tan
IPC分类号: A61K31/538 , A61K31/421 , A61K31/423 , A61K31/42 , A61K31/41
CPC分类号: C07D263/32 , C07D265/02
摘要: The present invention relates to compounds of formula I: wherein A, X, R1, R2 and R3 are as defined herein and pharmaceutically acceptable salts thereof. The invention also relates to methods of using the compounds of formula I and pharmaceutical compositions comprising the compounds of formula I.
摘要翻译: 本发明涉及式I化合物:其中A,X,R 1,R 2和R 3如本文所定义和药学上 其可接受的盐。 本发明还涉及使用式I化合物和包含式I化合物的药物组合物的方法。
-
公开(公告)号:US08163906B2
公开(公告)日:2012-04-24
申请号:US12152432
申请日:2008-05-14
申请人: Sarah C. Abbot , Geneviève N. Boice , Bernd Buettelmann , David Michael Goldstein , Leyi Gong , Joan Heather Hogg , Pravin Iyer , Kristen Lynn McCaleb , Yun-chou Tan
发明人: Sarah C. Abbot , Geneviève N. Boice , Bernd Buettelmann , David Michael Goldstein , Leyi Gong , Joan Heather Hogg , Pravin Iyer , Kristen Lynn McCaleb , Yun-chou Tan
IPC分类号: C07D471/04
CPC分类号: C07D215/48 , C07D401/06 , C07D401/12 , C07D405/06 , C07D405/12 , C07D413/04 , C07D471/04
摘要: Compounds of formula I are effective modulators of JNK: wherein X is CR11 or N; Y is —C(O)R3, 5-membered heteroaryl, or 5-membered heterocyclyl; Z is phenyl, cycloalkyl, heterocyclyl or heteroaryl, and is substituted with R1 and R2; R1 and R2 are each independently H, halo, CN, lower alkyl, or —Y1—Y2—Y3—R8, or R1 and R2 together form —O(CH2)nO—, where n is 1 or 2; Y1 is —O—, —C(O)—, —C(O)O—, —C(O)NR9—, —NR9C(O)—, —S—, —SO2—, or a bond; Y2 is cycloalkylene, heterocycloalkylene, lower alkylene or a bond; Y3 is —O—, —C(O)—, —C(O)O—, —C(O)NR9—, —NR9C(O)—, —SO2—, or a bond; R8 is H, lower alkyl, lower alkoxy, cycloalkyl, heterocycloalkyl, or —NR9R10, wherein R8 other than H is optionally substituted with lower alkyl, halo, —CF3, or —OH; R9 and R10 are each independently H or lower alkyl; R3 is OH, lower alkyl, lower alkoxy, (lower alkoxy)-lower alkoxy, or —NR9R10; R4 is lower alkyl, phenyl, heterocyclyl, cycloalkyl, heterocycloalkyl, or heteroaryl, and is optionally substituted with lower alkyl, hydroxy, lower alkoxy, halo, nitro, amino, cyano, or halo-lower alkyl; R5 and R6 are each independently H, halo, cyano, lower alkyl, —CF3, lower alkoxy, —OCHF2, —NO2, or —NR9R10; R7 is H, F, Cl, methyl, or OH; R11 is H, lower alkyl, lower cycloalkyl, or phenyl; or a pharmaceutically acceptable salt thereof.
摘要翻译: 式I化合物是JNK的有效调节剂:其中X是CR11或N; Y是-C(O)R 3,5元杂芳基或5元杂环基; Z是苯基,环烷基,杂环基或杂芳基,并被R1和R2取代; R1和R2各自独立地为H,卤素,CN,低级烷基或-Y1-Y2-Y3-R8,或R1和R2一起形成-O(CH 2)n O-,其中n为1或2; Y1是-O - , - C(O) - , - C(O)O - , - C(O)NR 9 - , - NR 9 C(O) - , - S - , - SO 2 - 或键; Y2是亚环烷基,杂环亚烷基,低级亚烷基或键; Y 3是-O - , - C(O) - , - C(O)O-,-C(O)NR 9 - , - NR 9 C(O) - , - SO 2 - 或键; R8是H,低级烷基,低级烷氧基,环烷基,杂环烷基或-NR9R10,其中R8以外的R8任选被低级烷基,卤素,-CF 3或-OH取代; R9和R10各自独立地为H或低级烷基; R3是OH,低级烷基,低级烷氧基,(低级烷氧基) - 低级烷氧基或-NR9R10; R 4是低级烷基,苯基,杂环基,环烷基,杂环烷基或杂芳基,并且任选被低级烷基,羟基,低级烷氧基,卤素,硝基,氨基,氰基或卤代低级烷基取代。 R 5和R 6各自独立地为H,卤素,氰基,低级烷基,-CF 3,低级烷氧基,-OCHF 2,-NO 2或-NR 9 R 10; R7是H,F,Cl,甲基或OH; R11是H,低级烷基,低级环烷基或苯基; 或其药学上可接受的盐。
-
公开(公告)号:US07868031B2
公开(公告)日:2011-01-11
申请号:US11635899
申请日:2006-12-08
申请人: Leyi Gong , Counde O'Yang , Yun-chou Tan
发明人: Leyi Gong , Counde O'Yang , Yun-chou Tan
IPC分类号: C07D271/06 , C07D263/32 , C07D261/08 , C07D235/38 , A61K31/216 , A61K31/4245 , A61K31/421 , A61K31/42
CPC分类号: C07D263/32 , C07C235/38 , C07C2601/04 , C07D271/06
摘要: The present invention relates to propionamide compounds of formula I for use as antiinflammatory agents: wherein R1, R2 and R3 are as defined herein and pharmaceutically acceptable salts thereof. The invention also relates to methods of using the compounds of formula I and pharmaceutical compositions comprising the compounds of formula I.
摘要翻译: 本发明涉及用作抗炎剂的式I的丙酰胺化合物:其中R1,R2和R3如本文所定义,及其药学上可接受的盐。 本发明还涉及使用式I化合物和包含式I化合物的药物组合物的方法。
-
公开(公告)号:US20080287458A1
公开(公告)日:2008-11-20
申请号:US12152432
申请日:2008-05-14
申请人: Sarah C. Abbot , Genevieve N. Boice , Bernd Buettelmann , David Michael Goldstein , Leyi Gong , Joan Heather Hogg , Pravin Iyer , Kristen Lynn McCaleb , Yun-chou Tan
发明人: Sarah C. Abbot , Genevieve N. Boice , Bernd Buettelmann , David Michael Goldstein , Leyi Gong , Joan Heather Hogg , Pravin Iyer , Kristen Lynn McCaleb , Yun-chou Tan
IPC分类号: A61K31/496 , C07D471/04 , A61P19/02 , A61K31/4375
CPC分类号: C07D215/48 , C07D401/06 , C07D401/12 , C07D405/06 , C07D405/12 , C07D413/04 , C07D471/04
摘要: Compounds of formula I are effective modulators of JNK: wherein X is CR11 or N; Y is —C(O)R3, 5-membered heteroaryl, or 5-membered heterocyclyl; Z is phenyl, cycloalkyl, heterocyclyl or heteroaryl, and is substituted with R1 and R2; R1 and R2 are each independently H, halo, CN, lower alkyl, or —Y1—Y2—Y3—R8, or R1 and R2 together form —O(CH2)nO—, where n is 1 or 2; Y1 is —O—, —C(O)—, —C(O)O—, —C(O)NR9—, —NR9C(O)—, —S—, —SO2—, or a bond; Y2 is cycloalkylene, heterocycloalkylene, lower alkylene or a bond; Y3 is —O—, —C(O)—, —C(O)O—, —C(O)NR9—, —NR9C(O)—, —SO2—, or a bond; R8 is H, lower alkyl, lower alkoxy, cycloalkyl, heterocycloalkyl, or —NR9R10, wherein R8 other than H is optionally substituted with lower alkyl, halo, —CF3, or —OH; R9 and R10 are each independently H or lower alkyl; R3 is OH, lower alkyl, lower alkoxy, (lower alkoxy)-lower alkoxy, or —NR9R10; R4 is lower alkyl, phenyl, heterocyclyl, cycloalkyl, heterocycloalkyl, or heteroaryl, and is optionally substituted with lower alkyl, hydroxy, lower alkoxy, halo, nitro, amino, cyano, or halo-lower alkyl; R5 and R6 are each independently H, halo, cyano, lower alkyl, —CF3, lower alkoxy, —OCHF2, —NO2, or —NR9R10; R7 is H, F, Cl, methyl, or OH; R11 is H, lower alkyl, lower cycloalkyl, or phenyl; or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US20110301171A1
公开(公告)日:2011-12-08
申请号:US13151326
申请日:2011-06-02
申请人: Humberto Bartolome Arzeno , Lubov K. Filonova , David Michael Goldstein , Leyi Gong , Bradley E. Loe , Erin M. O'Brien , Wylie Solang Palmer , David Mark Rotstein , Tania M. Silva , Yun-Chou Tan
发明人: Humberto Bartolome Arzeno , Lubov K. Filonova , David Michael Goldstein , Leyi Gong , Bradley E. Loe , Erin M. O'Brien , Wylie Solang Palmer , David Mark Rotstein , Tania M. Silva , Yun-Chou Tan
IPC分类号: A61K31/506 , C07D409/14 , A61P3/10 , C07D487/08 , A61P29/00 , A61P11/06 , C07D401/14 , C07D403/14
CPC分类号: C07D403/04 , C07D401/04 , C07D401/14 , C07D403/14 , C07D409/14 , C07D487/02
摘要: Compounds of formula I or pharmaceutically acceptable salts thereof, wherein R5 is a group of formula (a) or (b): and wherein m, n, p, q, X, Y, R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as defined herein. The compounds and compositions disclosed herein are useful to modulate the activity of JNK and treat diseases associated with JNK activity.
摘要翻译: 式I化合物或其药学上可接受的盐,其中R 5是式(a)或(b)的基团:其中m,n,p,q,X,Y,R 1,R 2,R 3,R 4,R 5,R 6 ,R7,R8和R9如本文所定义。 本文公开的化合物和组合物可用于调节JNK的活性并治疗与JNK活性相关的疾病。
-
公开(公告)号:US20110301170A1
公开(公告)日:2011-12-08
申请号:US13151323
申请日:2011-06-02
申请人: Leyi Gong , Yun-Chou Tan
发明人: Leyi Gong , Yun-Chou Tan
IPC分类号: A61K31/506 , A61P11/06 , A61P3/10 , C07D487/04 , A61P29/00
CPC分类号: C07D487/04
摘要: Compounds of formula I or pharmaceutically acceptable salts thereof, wherein: wherein m, n, p, q, X Y, Z, A, R1, R2, R3, R4, R5 and Y6 are as defined herein. The compounds and compositions disclosed herein are useful to modulate the activity of JNK and treat diseases associated with JNK activity.
摘要翻译: 式I化合物或其药学上可接受的盐,其中:其中m,n,p,q,X Y,Z,A,R 1,R 2,R 3,R 4,R 5和Y 6如本文所定义。 本文公开的化合物和组合物可用于调节JNK的活性并治疗与JNK活性相关的疾病。
-
公开(公告)号:US20070135500A1
公开(公告)日:2007-06-14
申请号:US11635899
申请日:2006-12-08
申请人: Leyi Gong , Counde O'Yang , Yun-chou Tan
发明人: Leyi Gong , Counde O'Yang , Yun-chou Tan
IPC分类号: A61K31/4245 , A61K31/421 , A61K31/42 , C07D271/10 , C07D263/34 , C07D261/06
CPC分类号: C07D263/32 , C07C235/38 , C07C2601/04 , C07D271/06
摘要: The present invention relates to compounds of formula I: wherein R1, R2 and R3 are as defined herein and pharmaceutically acceptable salts thereof The invention also relates to methods of using the compounds of formula I and pharmaceutical compositions comprising the compounds of formula I.
摘要翻译: 本发明涉及式I化合物:其中R 1,R 2和R 3如本文所定义及其药学上可接受的盐。 本发明还涉及使用式I化合物和包含式I化合物的药物组合物的方法。
-
公开(公告)号:US07348322B2
公开(公告)日:2008-03-25
申请号:US11636037
申请日:2006-12-08
申请人: Leyi Gong , Counde O'Yang , Yun-chou Tan
发明人: Leyi Gong , Counde O'Yang , Yun-chou Tan
IPC分类号: C07D265/02 , C07D261/20 , A61K31/538 , A61K31/421
CPC分类号: C07D263/32 , C07D265/02
摘要: The present invention relates to compounds of formula I: wherein A, X, R1, R2 and R3 are as defined herein and pharmaceutically acceptable salts thereof. The invention also relates to methods of using the compounds of formula I and pharmaceutical compositions comprising the compounds of formula I.
摘要翻译: 本发明涉及式I化合物:其中A,X,R 1,R 2和R 3如本文所定义和药学上 其可接受的盐。 本发明还涉及使用式I化合物和包含式I化合物的药物组合物的方法。
-
-
-
-
-
-
-
-